decisions are reached when MDTs incorporate patient-centered information into decision making alongside biomedical disease related information (Lanceley, Savage, Menon, & Jacobs, 2008) . More recently, a national survey by NCAT into attitudes toward MDT working among health care professionals in the UK has shown that MDT members regard information on patients' psychological, social, and health issues as integral to decision making by MDTs (NHS, National Cancer Action Team, 2009) . This has been supported by other work by our own research group (Lamb, Brown et al., 2011; Lamb, Sevdalis, Vincent, & Green, 2012) .
Problem Statement
No studies have been published that investigate what patients think of MDTs or whether their experience reflects the perceptions of health care professionals, researchers, and policymakers. It is crucial that any process that intends to be patient-centered is grounded in what patients consider to be important. Without knowledge of patients' perceptions about the MDT or their opinions of how they can best be represented in decision making, the MDT decision-making process risks veering away from what patients consider important to them.
Purpose
The aim of the study was to explore the perceptions and experiences of cancer patients regarding patient involvement in the clinical decision-making process by multidisciplinary cancer teams.
Research Questions
Research questions were created specifically to:
• Explore patients' understanding and experience of the purpose of an MDT.
• Investigate patients' views on how they would like their views and preferences to be incorporated into MDTs' decision-making.
• Elicit patients views on whom they feel would be best suited to represent them, assuming that they themselves cannot attend meetings.
• Elicit patients' views on how they want the outcome of MDT decisions to be communicated to them and how they can be involved in decision-making with the MDT.
Methods

Study Design
Topics such as this one that aim to explore in detail patients' attitudes and beliefs around issues related to their health care require a methodology that allows the researcher to delve in detail into the patient's thinking. Survey or experimental approaches are thus not well-suited to these types of research questions. Instead, we opted for a qualitative approach designed to enable exploration of participants' experiences and opinions. The focus group approach ensured feasibility of the research within our hospital setting (semistructured interviews were considered as a viable methodological alterative using the same topic guide; however, they were not feasible to carry out).
Setting
The study was conducted at two NHS District General Hospitals in England: Whipps Cross University Hospital, London, and The Royal Surrey County Hospital, Guildford. Whipps Cross Hospital has approximately 730 beds and is situated in northeast London. The hospital serves a range of populations from diverse ethnic populations from inner-city
Research Summary
Background
Cancer care is increasingly being delivered by multidisciplinary teams (MDTs); however, little is known of what patients think of or understand about the role of the MDT in cancer care.
Purpose
To explore patients' understanding and experience of the purpose of an MDT and to investigate patients' views on how they would like to be involved in the decision-making process.
Methods
Three focus groups, consisting of 21 individuals with a history of cancer, were conducted. A framework analytical approach was used to code data and supporting quotes were extracted.
Results
Participants felt it was important to consider biomedical, psychosocial, and patients' preferences in clinical decisionmaking, although this was not always their experience. Participants were not keen on attending their own case discussion; they felt that they could contribute indirectly via the clinical nurse specialist (CNS), that cases should only be discussed when attendant members knew the patient and that it is important that they are supported when being given diagnoses and treatment options.
Conclusions
Our results suggest that patients are positive towards MDT working, but improvements must be made regarding informing patients about the MDT and representing their interests in MDT meetings. Nurses have an important role as patient advocates and in promoting the interests of patients at MDT meetings.
Level of Evidence -VI
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London to a more suburban Greater London and Essex population, which tends to be majority Caucasian British. The Royal Surry County Hospital has approximately 520 beds and serves a population from a mixture of urban, suburban, and rural areas from Surrey and the surrounding counties. The majority of the local population is of Caucasian British ethnicity. Both hospitals provide a range of services including emergency care and cancer services. Both hospitals have a number of groups for patients to join for social support, share their experiences, and participate in service improvement. We contacted the representatives from cancer patients' groups at each hospital asking if they would participate.
Sampling Strategy
Purposive sampling was used to recruit patients previously treated by MDTs and ensure a diverse sample that collects opinion from a range of social and cultural groups. Inclusion criteria were that participants must be adults, who speak English, and have been diagnosed with or treated for cancer at an NHS hospital. Participants were recruited via local patient groups through group representatives. Three focus groups were organized because our research group's experience suggested this was when the emerging themes reached saturation point. Focus groups were planned to occur at NHS Trusts and last approximately two hours.
Ethical approval for the study was given by the South East London Research Ethics Committee as well as locally by the Research and Development departments of the NHS Trusts concerned. Informed written consent was sought from all participants prior to participation.
Interview Guide
The researcher followed a semi-structured open-ended list of questions to obtain and explore participants' views on MDTs in cancer care. The question list has been developed by the research team (which includes a patient safety researcher, urological surgeons, a health psychologist, and an oncologist) based on the literature outlined in the introduction. Several themes were identified based on our groups' extensive research on cancer MDTs and also the existing evidence base, which were then covered in a semi-structured manner such that the researchers used the topic guide in a flexible manner, taking into account the thought flow of participants. Themes included 1) patients' experience of cancer diagnosis and/or treatment, 2) awareness of the role and makeup of the MDT, 3) experiences of being treated by and/or interacting with a cancer MDTs, 4) information that is felt to be important for the MDT to consider, 5) patient representation and attendance at MDT meetings, 6) communication of MDT outcomes to patients, and 7) patient involvement in decision-making with the MDT.
Procedures
Three focus groups were held. The first was in Essex in October 2010 that was attended by nine participants (1 hour: 45 minutes); a second was in Surrey in August 2011 that was attended by six participants (1 hour: 30 minutes), and a third was in London in October 2012 that was attended by seven participants (1 hour: 24 minutes). All focus groups were carried out by a team of researchers with training and expertise in qualitative methodologies and good understanding of current cancer care pathways in the UK. Focus groups were all conducted in person, the first by a psychologist and a surgeon, the second by a surgeon alone, and the third by two surgeons. The focus groups were recorded with a digital voice recorder.
Data Analysis
A standard approach was taken in the analysis of the qualitative datasets that were derived from the focus groups. First, all focus groups were audio recorded and transcribed verbatim. Transcripts were then coded by one researcher before themes were checked for content by a second researcher. A grounded theory approach was applied whereby a skeleton coding framework was devised based on the topic guide and data were coded to those primary codes; new codes were then added as new themes emerged in the data. In other words, the coding scheme evolved in line with the emerging data from the transcripts (Pope, Ziebland, & Mays, 2000) . The dual coding, which included a surgeon and a psychologist coders, ensured multidisciplinary expertise and a balanced approach to the transcript contents and the derived codes. Verbatim quotes were finally extracted to support and illustrate the codes.
Results
Participants
A total of 21 individuals participated in the study (males, n =19, 90.5%; females, n = 2, 9.5%). Of the participants, 16 (76.2%) had been diagnosed with prostate cancer, two (9.5%) with breast cancer, two (9.5%) with upper gastrointestinal cancer, and one (4.8%) with sarcoma. They ranged in age from 60 to 81 years (M = 69.8, SD = 7.48). The majority (n = 20, 95.2%) were of Caucasian British ethnicity, and one (4.8%) was Black British.
Patients' Awareness and Opinion of MDTs
None of the participants in one focus group and two of the participants in the second had heard of the MDT at the time of their treatment. Other participants reported that they became aware of a team structure as their care progressed, and all found the idea of being treated by a team to be reassuring. Parti cipants generally felt that a team approach to cancer care would mean that patients are offered a
wider range of treatments than those provided by the clinician they might personally see. The phrase MDT was not popular with group members; they felt it was jargonistic and did not reflect their understanding of the team meeting. Patients preferred the name case-conference instead. The majority of participants knew that surgeons, oncologists, and nurses were MDT members, but there was little awareness of the professional groups of other team members. Participants felt that confronting a whole team would be intimidating, and they would prefer to have contact only with individual team members. Regarding the cases that might require MDT discussion, participants felt that the inclusion criteria, as they stand, are reasonable. Participants were open to the idea of streamlining the MDT meeting by prioritizing cases or treating some straightforward cases by chair's action rather than a full discussion (see Table 1 ).
Information that Patients Want the MDT to Consider in Decision-Making
Members felt strongly that biomedical information and pathology, in particular, was the most important information to consider, and without this, it would be impossible to arrive at the correct diagnosis or treatment. After information about the disease in question, participants felt that information about a patient's fitness and social circumstances were also crucial to ensure that decisions were appropriate. There was a mix between trust in the MDT, a feeling that they knew all they needed to make good decisions, although others did not trust that MDT members would have the time or inclination to consider patient's preferences or their individual circumstances.
Regarding who might collect information on patient's circumstances and fitness, participants felt that the nurse was the easiest person to talk to and would be best able to gather this information. Patients had experienced assessment of their fitness, often by the operating surgeon. How ever, only one patient had been asked about family life, and the clinical nurse specialist (CNS) recorded those details between visits for endoscopy. One participant went further and said that he had tried telling his clinicians about his comorbid conditions that may complicate surgery but that he was not listened to until just before surgery, which was subsequently cancelled, causing considerable distress (see Table 2 ).
Opinion about Attending/ Representation in MDT Meeting
Several participants felt they could potentially be directly involved in their own case discussion and that their personal contribution would add value to the decision-making process. However, there were others who felt their presence in the MDT meeting would inhibit full and frank discussion of their case by MDT members, as well as being distressing to themselves. In addition, some participants thought that MDT members would know everything that was relevant, and as such, their participation would not add any benefit.
Participants were unanimous in their opinion that the nurse was the member of the MDT with whom they had the best relationship and who would be best placed to ascertain information on their social circumstances, personal views, and even information of a more intimate nature. By virtue of the fact that the CNS has a good relationship with patients, most participants felt that in the absence of the patients in the MDT meeting themselves, the CNS was the team member best placed to act as a patient advocate. One participant raised the point that all team members 
should have the patients' best interest in mind and should do their best to act in the patients' best interest, an idea to which other participants gave their approval. Another participant discussed whether the CNS should have a formal role as patient advocate, with the official responsibility of representing patients' views and circumstances in meetings. The occurrence of hierarchies in the MDT meeting and particularly the way in which this limited the input of nurses were discussed. Participants all found this concerning, but many felt this style of teamwork was outdated and was changing with the increasing recognition that CNS played a unique and valuable contribution to the MDT meeting.
Participants felt strongly and unanimously that patients' cases should only be discussed if someone was present who personally knew the patient. Many participants were incredulous at the idea of being discussed without being known. Someone raised the idea that if there were no team member who knew them present, they would rather delay case discussion until someone they knew was present. The majority of other participants supported this idea.
Participants were generally not keen on the idea of having a patient representative in the MDT meeting. They felt that such a role would be too demanding for the individual and may be unpopular with patients and team members should they misrepresent the patient or the opinion of the team. Participants did not give much support for the involvement of their general practitioner (GP) as their representative in meetings, largely because they do not have close relationships to an individual GP, as was the case in previous times (see Table 3 ).
Opinion about Receiving Information from MDT Meeting
There was variation in the amount of information that participants thought patients would want following discussion of their case at the MDT meeting. All participants wanted to be informed of the outcome of meetings; some wanted only to be informed of the decision, whereas others wanted to be given details about different possible options, as well as the presence of any differing opinions from team members or any disagreement. Several participants articulated that the outcome of the MDT meeting should be tailored to the preferences of the individual patient because some would want choice and information, but others would want a more pater- Importance of social factors "If people have got a wife or a husband, and how fit they are can also be brought in." (F, 60) Importance of patient's circumstances "I think we are in cloud cuckoo land. I don't think the patient, other than the direct circumstances, is going to be dealt with." (M, 74) Trust that MDT will know all they need to "Somebody attending the meeting will know my blood pressure, my heart, my diet, all the rest of it that makes me, me, and how it will best fit into the various courses of treatment available." (M, 74) Nurse who gathers patient-centered information "But it's the nurse that sits with the patients and finds out what makes them tick and all about them and is, therefore, able to put the patient." (M, 70)
Experience of assessing fitness before surgery "I was asked to do exercises and run up and down stairs to see if I was fit, etc; to see if I could cope. And I think it wasn't specifically said to me that he was trying to assess whether it was worthwhile." (M, 60)
Experience of being asked about social factors "I was never asked about family or anything else." (M, 79)
Experience of seeing CNS "I was coming back for another one [endoscopy] , and then the clinical nurse specialist got involved: family life, family history, and that's when it all started. That was two weeks before surgery." (M, 70)
Experience of co-morbidities not being taken into account "I had recent inguinal hernia operation, and there was a large mesh in the way. I didn't find out until the last minute that they had not realized I had a mesh. I was told, 'Well, you can't have surgery now.' I kept telling them, and nobody seemed to take it into account." (M, 61)
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nalistic and prescriptive approach. Where choice over possible treatments might exist, it was felt that members of the MDT with particular treatment expertise might not be able to give a balanced view of all the different options available. In that instance, the view was raised that it would be best to discuss options with the respective practitioners, in sequence, to get a balanced view. This opinion was countered by other participants who felt that it would be best to talk to an MDT member, such as the CNS, who did not have a particular treatment expertise but who could give a balanced overall picture of the pros and cons. This opinion was strengthened by the trust that participants had in the CNS they knew and the ease with which they could talk to them. Participants reported a range of experiences regarding being given information about diagnosis and treatment. Experiences ranged from being given little information on a variety of options to a good amount of information on a single option to a single option with no information. There did not seem to be an association between the amount of information patients were given about their diagnosis and treatment and their satisfaction with the treatment they received. The only criticism came from patients who had not been prepared to be given information about the diagnosis and found it very distressing and therefore difficult to take in. Those patients found there was no continuity of care, so they did not have the rapport with the clinician who was giving them information, which made it difficult to interpret (see Table 4 ).
Opinion/Experience of Patients' Role in DecisionMaking after the MDT Meeting
Participants generally agreed that any decision making at the time of diagnosis was very difficult because of the news being overwhelming. Some participants intimated they would rather have a clinician they trusted to make decision for them than to make decisions for them- Concerned that presence would disrupt discussion "My problem is if I'm sitting there, and I'm putting the professionals off frank discussion." (F, 65) Timing of MDT meeting difficult "I don't think you're in the right frame of mind when you're diagnosed." (M, 62)
Relationship with nurse "You can talk [to the CNS] about anything and everything; she knows more about us than we do or our partners do." (M, 60)
All MDT should speak for patient "I think the nurse is the patient advocate in that group. But they should all have the patient's benefits at heart." ( 
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selves, although others said they would rather deicide themselves. Participants felt that patients should be able to make decisions with the help of carers and family and that, if a choice were available, the patient should also be supported by members of the MDT to come to a decision that was tailored to his or her circumstances. When making decisions about different treatments, participants said that in addition to considering factors such as the side effects of different treatments, issues such as the reputation and location of potential treating hospitals would be important.
Regarding factors that had helped participants make decisions in the past, some had spoken to friends who had similar experiences, whereas others were put in touch with past patients by the clinician treating them. In both cases, participants said talking to other patients was helpful and they would also talk to their GP to get advice. Participants thought the amount of weight the MDT opinion carried would depend on the unanimity of any recommendation, and although disagreement within the MDT might make decision making more difficult for them, they would rather be informed (see Table 5 ).
Discussion
As the first study to address patients' views and experiences of MDTs in cancer care, the present study gives an initial picture of what patients think about MDTs and how they want to be represented and included in the decision-making process. Awareness about the MDT among participants was low, but they found the idea reassuring. Participants felt it was important to consider all relevant information, biomedical, psychosocial, as well as preferences, although their experience showed that this was not always the case. While participants were not keen on attending their own case discussion, they felt that they could contribute indirectly via the CNS, who by virtue of the close relationship with patients, had a special role in gathering information and could act as an advocate in the MDT meeting. Participants felt it was important that cases were only discussed when there were members present who knew the patient; otherwise, they thought it would be preferable to delay discussion. Participants felt it was important that they were well supported when being given diagnoses and treatment options, including impartial and clear Amount of choice should be tailored to patient "It's part of the assessment whether the patient is going to be stressed out by being offered choice." (M, 83) Specialist should give own information "Well, if its essential surgery, I think it needs to be the surgeon. If it's chemo or radio, or something like that, then probably the oncologist, in conjunction with the nurse." (M, 70) Concern that patients are not given whole choice "The surgeon could be biased in favor of this particular treatment, and the radiotherapist and the oncologist, too." (M, 74)
CNS unbiased "The nurse is so valuable because they don't have the same biases, perhaps, as the surgeon and the oncologist." ( information from a range of sources, with adequate time to decide. The idea of being treated by a MDT is a popular idea among the patients involved in this study. However, at the time of diagnosis and treatment, their awareness of the existence and purpose of the MDT was low. Patient satisfaction is increasingly important as a marker of performance in health care (Department of Health, 2010a . Promoting the aspects of care that patients find appealing may improve the experience of patients and increase their satisfaction with health care services. Raising the awareness of the MDT among patients where MDTs are mandatory, such as in the UK, may improve satisfaction. Where MDTs are not mandatory, such an arrangement may improve patient satisfaction, as well as potentially improving outcomes (Kesson et al., 2012) .
Improvements in patient outcomes in recent years have been achieved, in part, as a result of an emphasis on the treatment of disease. This approach has been successful, and survival rates for many cancers have improved; however, living with a diagnosis of cancer places significant physical and emotional burdens on patients and their families (Department of Health, 2000) . Many of these patients will not be cured and will, therefore, continue to feel the distressing impact of their illness on their physical and psychological health in the long-term (Ahmedzai & Walsh, 2000) . In addition to treatment, supportive care is needed to help patients and families cope with the effects of the disease. Supportive care involves providing physical and emotional care, and encouraging and supporting participation in decision making (Willard & Luker, 2005) . In the UK, the National Institute for Health and Clinical Excellence (2004) states that supportive care should be given equal priority alongside diagnosis and treatment. A holistic cancer care program must be underpinned by decision making that recognizes these supportive aspects of cancer care.
Patient-related outcome and experience measures widely used in other domains of heath care might be developed for use in relation to multidisciplinary cancer care. Such objective outcome and experience measures could be used to assess the strengths and weaknesses of teams' interactions with their patients and to inform areas for improvement. Similarly, there are currently no tools for MDTs to assess the "patient centeredness" of their decision-making process, and future research should aim to inform teams of the desirable aspects of patient centeredness, and how these can be assessed and improved.
Implications
One implication of the findings of this study is whether there are circumstances in which case discussions should not pro- Would rather be given a choice of treatments "I'm not taking the drug to which I am entitled; I chose not to take it, at the moment, anyway. I don't want the side effects, and I discussed it with the oncologist and the surgeon and the radiologist...they gave me that choice." (F, 65) Experience (Lamb et al., 2012) . After all, it would not be appropriate to start an operation without the right equipment available. Similarly, it may be that discussion of a patient at the MDT meeting should not proceed without a minimum dataset for clinical information, information about the patient's circumstances, or their views, or even without the presence of a team member who has met the patient. Further research is needed to confirm our provisional results with a more representative sample of patients and to assess the feasibility of such an approach in view of the demands of service provision.
These initial results also have implications for the role of the CNS in the MDT. Our results confirm the findings of previous research that patients value nurses as the team member with whom they can relate and who can act as an interface between the patient and the health care system (Amir, Scully, & Borrill, 2004; Department of Health, 2010b) . The importance of the CNS to patients is reinforced by the results of the UK cancer patients' survey, which showed that the only feature that predicted patients' ratings of cancer teams was the number of CNSs in the team (Department of Health, 2010b) .
Recent research has suggested that the advocacy role of CNS can become compromised by an increasing administrative workload (Leary et al., 2008) . Restructuring of the role of the CNS to reduce administrative workload and strengthen the role of CNS as patient advocates and representatives in MDT meetings might increase patient satisfaction as well as the quality of MDT decision-making.
Limitations
The results of this study are subject to certain limitations. The sample size in this study is small, and therefore, may not be representative of the population in general. However, qualitative work does not generally require large sample sizes, and in the present study, saturation point was reached, suggesting that the sample size was sufficient. Participants may not be representative of the population as a whole, and there were a minority of women participating in the study, although participants were selected from diverse locations and social groups to access opinion from different parts of society. Further, the findings from this UK study may not be applicable to health care systems where MDTs are not as widespread. Future research might examine the views of a larger range of patients across different health care systems and social groups before generalizations can be made with any certainty.
Conclusions
Patient-centered care is crucial for high-quality care, and it follows that the interests of patients should be at the heart of the cancer MDT meeting. Our results suggest that patients are positive towards the idea of MDTs, but in practice, progress must be made regarding informing patients about the MDT and representing patients' interests in the MDT meeting. This study also reinforces the role of the CNS as a core member of the cancer MDT and highlights the importance of their role to patients.
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